相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients
Minghao Li et al.
SCIENTIFIC REPORTS (2022)
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
Mathieu Gigoux et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
The distribution of cellular turnover in the human body
Ron Sender et al.
NATURE MEDICINE (2021)
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
Jacob Handlos Grauslund et al.
FRONTIERS IN ONCOLOGY (2021)
PD-1 inhibition in advanced myeloproliferative neoplasms
Gabriela Hobbs et al.
BLOOD ADVANCES (2021)
Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development
Thomas Balligand et al.
LEUKEMIA (2020)
Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer
Morten Orebo Holmstrom et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
Morten Orebo Holmstrom et al.
CANCERS (2020)
Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens
Morten Orebo Holmstrom et al.
CANCERS (2020)
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms
Fiorella Schischlik et al.
BLOOD (2019)
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
Sabrina Cordua et al.
BLOOD (2019)
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasmas
Cansu Cimen Bozkus et al.
CANCER DISCOVERY (2019)
High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals
Morten O. Holmstrom et al.
BLOOD CANCER JOURNAL (2019)
Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantation
Jennifer Mosebach et al.
HAEMATOLOGICA (2018)
The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy
M. O. Holmstrom et al.
LEUKEMIA (2018)
Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes
Lasse Kjaer et al.
LEUKEMIA & LYMPHOMA (2018)
Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantation
Jennifer Mosebach et al.
HAEMATOLOGICA (2018)
Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR
Hiroyasu Ogawa et al.
BONE MARROW TRANSPLANTATION (2018)
Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I
Najla Arshad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment
James L. Gulley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy
Robert Sackstein et al.
LABORATORY INVESTIGATION (2017)
Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
Stephan Halle et al.
TRENDS IN IMMUNOLOGY (2017)
Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment
James L. Gulley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis
Marco Romano et al.
ONCOIMMUNOLOGY (2017)
Next-generation deep-sequencing detects multiple clones of CALR mutations in patients with BCR-ABL1 negative MPN
S. Jeromin et al.
LEUKEMIA (2016)
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
D. Pietra et al.
LEUKEMIA (2016)
The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms
M. O. Holmstrom et al.
LEUKEMIA (2016)
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment
Lasse Kjaer et al.
PLOS ONE (2016)
More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers
Garry Dolton et al.
IMMUNOLOGY (2015)
Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
Trine Zeeberg Iversen et al.
CLINICAL CANCER RESEARCH (2014)
The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors
Osama E. Rahma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
An Immune Dysregulation in MPN
Giovanni Barosi
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2014)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response
Katarzyna Franciszkiewicz et al.
CANCER RESEARCH (2012)
Response definition criteria for ELISPOT assays revisited
Z. Moodie et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Mechanisms of disease: The myeloproliferative disorders
Peter J. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
